Literature DB >> 30543339

Error in Figure 2.

.   

Abstract

Year:  2018        PMID： 30543339      PMCID： PMC8177376          DOI： 10.1001/jamaoncol.2018.6227

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial.

Authors:  Cesare Gridelli; Javier de Castro Carpeno; Anne-Marie C Dingemans; Frank Griesinger; Francesco Grossi; Corey Langer; Yuichiro Ohe; Konstantinos Syrigos; Nick Thatcher; Ashis Das-Gupta; Matt Truman; Margarita Donica; Vlatka Smoljanovic; Jaafar Bennouna
Journal:  JAMA Oncol       Date:  2018-12-13       Impact factor: 31.777
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.